Douglas Ingram
Net worth: 12 M $ as of 31/05/2026
Net worth: 12 M $ as of 31/05/2026
Douglas S. Ingram occupies the position of President, Chief Executive Officer & Director at Sarepta Therapeutics, Inc. He is also on the board of Allergan Foundation and Relay Therapeutics, Inc. He previously held the position of Attorney at Gibson, Dunn & Crutcher LLP, Chief Executive Officer & Director at Chase Pharmaceuticals Corp. and President for Allergan, Inc. Mr. Ingram received an undergraduate degree from Arizona State University and a graduate degree from the University of Arizona.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 08/04/2026 | 390,307 ( 0.37% ) | 7 M $ | 31/05/2026 | |
| 15/01/2026 | 59,016 ( 0.04% ) | 5 M $ | 31/05/2026 | |
| 09/06/2026 | 25,000 ( 0.01% ) | 351 250 $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Chief Executive Officer | 26/06/2017 |
| RELAY THERAPEUTICS, INC. | Director/Board Member | 01/06/2019 |
Allergan Foundation | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Director/Board Member | 19/03/2026 |
Pacific Mutual Holding Co.
Pacific Mutual Holding Co. Insurance Brokers/ServicesFinance Provides insurance, financial and other investment services | Director/Board Member | 01/05/2018 |
| SKYE BIOSCIENCE, INC. | Director/Board Member | 19/01/2018 |
| ENDO INTERNATIONAL PLC | Director/Board Member | 06/11/2017 |
Chase Pharmaceuticals Corp.
Chase Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops novel medications for the treatment of Alzheimer’s disease | Chief Executive Officer | 01/11/2016 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 15 |
|---|---|
Allergan, Inc.
Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Gibson, Dunn & Crutcher, Inc.
Gibson, Dunn & Crutcher, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a law firm | Commercial Services |
Arrowhead Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drugs to treat intractable diseases | Health Technology |
Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Pacific Mutual Holding Co.
Pacific Mutual Holding Co. Insurance Brokers/ServicesFinance Provides insurance, financial and other investment services | Finance |
ECC Capital Corp.
ECC Capital Corp. Real Estate Investment TrustsFinance Provides mortgage finance real estate investment trust services | Finance |
Volcom, Inc.
Volcom, Inc. Apparel/FootwearConsumer Non-Durables Manufactures and distributes clothes and accessories | Consumer Non-Durables |
Chase Pharmaceuticals Corp.
Chase Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops novel medications for the treatment of Alzheimer’s disease | Health Technology |
Endo International Plc
Endo International Plc Pharmaceuticals: MajorHealth Technology Develops and manufactures immunology, urology, hepatology, generics & sterile injectables therapeutics products | Health Technology |
Arizona State University
Arizona State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Arizona
University of Arizona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pacific Life Insurance Co.
Pacific Life Insurance Co. Life/Health InsuranceFinance Provides life insurance products, annuities and mutual funds solutions | Finance |
Allergan Foundation | Health Services |
Skye Bioscience, Inc.
Skye Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets cannabinoid derivatives to treat ophthalmic disorders | Health Technology |
Relay Therapeutics, Inc.
Relay Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage precision medicine company, which focus on enhancing small molecule therapeutic discovery in targeted oncology | Health Technology |
Select your edition
All financial news and data tailored to specific country editions